Form 4 for HCA HCA Healthcare
Accepted 2024-03-20 00:00:00 ET · period of report 2024-03-18 · accession 0001209191-24-004999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-20 | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | M - OptEx | $101.16 | +2,100 | 4,020 | +109% | +$212.4K |
| D | 2024-03-20 | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | F - Tax | $327.17 | -1,224 | 2,796 | -30% | -$400.5K |
| DM | 2024-03-20 | 2024-03-18+ | HCA | Wasserman Chad J | SVP, CIO | S - Sale+OE | $327.92 | -1,220 | 1,576 | -44% | -$400.1K |
| D | 2024-03-20 | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | M - OptEx | $0.00 | -2,100 | 4,190 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-18 | M | A | 2,100 | $101.16 | 4,020.31 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-18 | F | D | 1,224 | $327.17 | 2,796.31 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-18 | S | D | 344 | $321.97 | 2,452.31 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-20 | S | D | 876 | $330.25 | 1,576.31 | D | — | — | |
| 5 | Derivative | Stock Appreciation Right | 2024-03-18 | M | D | 2,100 | $0.00 | 4,190 | D | $101.16 · — to 2028-01-31 | 2,100 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |